Eye Solution Recalled
Promise Pharmacy recalls one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3mL vials due to particulates in the solution.
Promise Pharmacy announced on Oct. 22, 2018 that it was voluntarily recalling one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3mL vials to the consumer level. The recall is in response to unidentified small particulates that were found floating in the solution. The affected lot number is 09042018@2 with an expiration of 12/03/2018 and was distributed nationwide.
The product is used as a post-surgical (cataract) ophthalmic treatment. While the company has not received reports of adverse events, it says that use of contaminated product could result in limited eye irritation, inflammation, visual impairment, or permanent ocular damage.
The company stated in a press release that patients should stop using the product and return it to the company. Adverse events may be reported to FDA through its MedWatch program.
Source: FDA
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
